The 16 references in paper T. Anokhina N., E. Anaev Kh., A. Revelsky I., A. Rodionov A., D. Alexeyev V., I. Revelsky A., V. Kudryavtsev B., Т. Анохина Н., Э. Анаев Х., А. Ревельский И., А. Родионов А., Д. Алексеев В., И. Ревельский А., В. Кудрявцев Б. (2014) “Диагностическая значимость среднелетучих органических соединений в конденсате выдыхаемого воздуха при бронхиальной астме и хронической обструктивной болезни легких // Diagnostic value of semi-volatile organic compounds in exhaled breath condensate of asthma and chronic obstructive pulmonary disease patients” / spz:neicon:pulmonology:y:2011:i:4:p:71-75

1
Чучалин А.Г. (ред.). Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2006 г. Пер. с англ. М.: издательский дом "Атмосфера"; 2007.
(check this in PDF content)
2
Чучалин А.Г.(ред.). Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2006: Пер. с англ. М.: издательский дом "Атмосфера"; 2007.
(check this in PDF content)
3
Fabbri L.M., Romagnoli M., Corbetta L. et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 418–424.
(check this in PDF content)
4
Decramer M., Selroos O. Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide / formoterol in a single inhaler (Symbicort) in both diseases. Int. J. Clin. Pract. 2005; 59: 385–398.
(check this in PDF content)
5
Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2005; 11: 7–13.
(check this in PDF content)
6
Moser B., Bodrogi F., Eibl G. et al. Mass spectrometric profile of exhaled breath-field study by PTR-MS. Respir. Physiol. Neurobiol. 2005; 145: 295–300.
(check this in PDF content)
7
Родионов А.А., Ревельский А.И., Ревельский И.А. и др. Хроматомасс-спектрометрическое определение среднелетучих органических веществ в конденсате выдыхаемого воздуха. Масс-спектрометрия 2007; 4 (2): 143–148.
(check this in PDF content)
8
Bhattacharya S., Srisuma S., Demeo D.L. et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am. J. Respir. Cell. Mol. Biol. 2009; 40: 359–367.
(check this in PDF content)
9
Gibson P.G., Simpson J.L.The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728–735.
(check this in PDF content)
10
Brasier A.R., Victor S., Boetticher G. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J. Allergy Clin. Immunol. 2008; 121: 30–37.
(check this in PDF content)
11
Weston A.D., Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004; 3: 179–196.
(check this in PDF content)
12
Crameri R. The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005; 60: 1227–1237.
(check this in PDF content)
13
Sepper R., Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J. Proteome Res. 2004; 3: 277–281.
(check this in PDF content)
14
Dragonieri S., Schot R., Mertens B.J. et al. An electronic nose in the discrimination of patients with asthma and controls. J. Allergy Clin. Immunol. 2007; 120: 856–862.
(check this in PDF content)
15
Dragonieri S., Annema J.T., Schot R. et al.An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009; 64: 166–170.
(check this in PDF content)
16
Fens N., de Nijs S.B., Roldaan A.C. et al.Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med. 2009; 180 (11): 1076–1082. Информация об авторах
(check this in PDF content)